Market Research Logo

North America Glucose Monitoring Market Outlook to 2022

North America Glucose Monitoring Market Outlook to 2022

Summary

GlobalData’s new report, North America Glucose Monitoring Market Outlook to 2022, provides key market data on the North America Glucose Monitoring market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Blood Glucose Meters, Blood Glucose Test Strips and Lancets.

The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Glucose Monitoring market segments - Blood Glucose Meters, Blood Glucose Test Strips and Lancets.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.
  • 2015 company shares and distribution shares data for each of the market segements.
  • Global corporate-level profiles of key companies operating within the North America Glucose Monitoring market.
  • Key players covered include LifeScan Inc, Medtronic plc, Bayer HealthCare AG, F. Hoffmann-La Roche Ltd and Others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Vision Care Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Glucose Monitoring Market, North America
3.1 Glucose Monitoring Market, North America, Revenue ($m), 2008-2022
3.2 Glucose Monitoring Market, North America, Category Comparison by Revenue ($m), 2008-2022
3.3 Glucose Monitoring Market, North America, Revenue ($m), 2008-2015
3.4 Glucose Monitoring Market, North America, Revenue ($m), 2015-2022
3.5 Glucose Monitoring Market, North America, Volume (Units), 2008-2022
3.6 Glucose Monitoring Market, North America, Volume (Units), 2008-2015
3.7 Glucose Monitoring Market, North America, Volume (Units), 2015-2022
3.8 Glucose Monitoring Market, North America, Company Share by Revenue ($m), 2015
4 Glucose Monitoring Market, Canada
4.1 Glucose Monitoring Market, Canada, Revenue ($m), 2008-2015
4.2 Glucose Monitoring Market, Canada, Revenue ($m), 2015-2022
4.2.1 Blood Glucose Meters Market, Canada, Revenue ($m), by Segment, 2008-2015
4.2.2 Blood Glucose Meters Market, Canada, Revenue ($m), by Segment, 2015-2022
4.3 Glucose Monitoring Market, Canada, Volume (Units), 2008-2015
4.4 Glucose Monitoring Market, Canada, Volume (Units), 2015-2022
4.4.1 Blood Glucose Meters Market, Canada, Volume (Units), by Segment, 2008-2015
4.4.2 Blood Glucose Meters Market, Canada, Volume (Units), by Segment, 2015-2022
4.5 Glucose Monitoring Market, Canada, Average Price ($), 2008-2022
4.6 Glucose Monitoring Market, Canada, Distribution Share by Revenue ($m), 2014-2015
4.7 Glucose Monitoring Market, Canada, Company Share by Revenue ($m), 2015
5 Glucose Monitoring Market, Mexico
5.1 Glucose Monitoring Market, Mexico, Revenue ($m), 2008-2015
5.2 Glucose Monitoring Market, Mexico, Revenue ($m), 2015-2022
5.2.1 Blood Glucose Meters Market, Mexico, Revenue ($m), by Segment, 2008-2015
5.2.2 Blood Glucose Meters Market, Mexico, Revenue ($m), by Segment, 2015-2022
5.3 Glucose Monitoring Market, Mexico, Volume (Units), 2008-2015
5.4 Glucose Monitoring Market, Mexico, Volume (Units), 2015-2022
5.4.1 Blood Glucose Meters Market, Mexico, Volume (Units), by Segment, 2008-2015
5.4.2 Blood Glucose Meters Market, Mexico, Volume (Units), by Segment, 2015-2022
5.5 Glucose Monitoring Market, Mexico, Average Price ($), 2008-2022
5.6 Glucose Monitoring Market, Mexico, Distribution Share by Revenue ($m), 2014-2015
5.7 Glucose Monitoring Market, Mexico, Company Share by Revenue ($m), 2015
6 Glucose Monitoring Market, United States
6.1 Glucose Monitoring Market, United States, Revenue ($m), 2008-2015
6.2 Glucose Monitoring Market, United States, Revenue ($m), 2015-2022
6.2.1 Blood Glucose Meters Market, United States, Revenue ($m), by Segment, 2008-2015
6.2.2 Blood Glucose Meters Market, United States, Revenue ($m), by Segment, 2015-2022
6.3 Glucose Monitoring Market, United States, Volume (Units), 2008-2015
6.4 Glucose Monitoring Market, United States, Volume (Units), 2015-2022
6.4.1 Blood Glucose Meters Market, United States, Volume (Units), by Segment, 2008-2015
6.4.2 Blood Glucose Meters Market, United States, Volume (Units), by Segment, 2015-2022
6.5 Glucose Monitoring Market, United States, Average Price ($), 2008-2022
6.6 Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), 2014-2015
6.7 Glucose Monitoring Market, United States, Company Share by Revenue ($m), 2015
7 Overview of Key Companies in North America Glucose Monitoring Market
7.1 LifeScan Inc
7.1.1 Company Overview
7.2 Bayer HealthCare AG
7.2.1 Company Overview
7.3 Abbott Laboratories
7.3.1 Company Overview
7.4 F. Hoffmann-La Roche Ltd
7.4.1 Company Overview
7.5 DexCom Inc
7.5.1 Company Overview
7.6 Medtronic plc
7.6.1 Company Overview
7.7 Arkray Inc
7.7.1 Company Overview
7.8 Becton Dickinson and Co
7.8.1 Company Overview
7.9 Trividia Health Inc
7.9.1 Company Overview
8 Glucose Monitoring Market Pipeline Products
9 Recent Developments
9.1 Corporate Communications
9.1.1 Sep 20, 2016: Livongo Health Lands Dave Engberg from Evernote as Chief Technology Officer
9.1.2 Aug 16, 2016: One Drop Expands Diabetes Health and Behavioral Informatics Team With Addition of Chandra Osborn PhD, MPH as Vice President
9.1.3 Aug 02, 2016: PositiveID Adds GenArraytion CEO R. Paul Schaudies, Ph.D. to its Board of Advisors
9.1.4 Aug 01, 2016: Zynerba Pharmaceuticals Announces Dosing of First Patients in Phase 2 STAR 1 Clinical Study of ZYN002 CBD Gel in Adult Epilepsy Patients with Refractory Focal Seizures
9.1.5 Jul 28, 2016: BD Names R. Andrew Eckert To Board Of Directors
9.1.6 Jun 28, 2016: WellDoc, a Digital Health Technology Leader, Expands Leadership Team with Roster of Seasoned Healthcare Executives
9.1.7 Jun 22, 2016: Johnson & Johnson Announces Retirement of Louise Mehrotra and Appointment of Joseph Wolk as Vice President of Investor Relations
9.1.8 Mar 23, 2016: GlucoTrack Maker Names Two New Board Members
9.1.9 Mar 15, 2016: M Pharmaceutical Announces Change to Management
9.1.10 Feb 26, 2016: Clinical Update On Thetanix For The Treatment Of Paediatric Crohn Disease : 4D Pharma
9.1.11 Jan 28, 2016: LivaNova Receives Regulatory Approval in Japan for KORA 250
9.1.12 Jan 19, 2016: Johnson & Johnson Announces Actions To Strengthen Medical Devices Leadership Position In Evolving Healthcare Marketplace
9.1.13 Jan 08, 2016: BioGaia’s subsidiary IBT has US IND open and Swedish CTA approved for clinical study
9.2 Financial Announcements
9.2.1 Nov 21, 2016: PositiveID Reports Revenue of $4.6 Million for First Nine Months of 2016, Up 70% from $2.7 Million for First Nine Months of 2015
9.2.2 Nov 04, 2016: Alere Reports Third Quarter 2016 Financial Results
9.2.3 Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance
9.2.4 Nov 01, 2016: Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 9.1 Percent
9.2.5 Nov 01, 2016: DexCom Reports Third Quarter 2016 Financial Results
9.2.6 Oct 27, 2016: Thermo Fisher Scientific Reports Third Quarter 2016 Results
9.2.7 Oct 18, 2016: Johnson & Johnson Reports 2016 Third-Quarter Results
9.2.8 Sep 27, 2016: PositiveID Announces Highlights for Third Quarter 2016
9.2.9 Sep 06, 2016: Alere Reports Second Quarter 2016 Financial Results
9.2.10 Aug 17, 2016: Alere Reports First Quarter 2016 Financial Results
9.2.11 Aug 15, 2016: PositiveID Reports Q2 2016 Revenue of $1.8 Million, Up from $51 Thousand in Q2 2015
9.2.12 Aug 08, 2016: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results
9.2.13 Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter
9.2.14 Aug 03, 2016: Bio-Rad Reports Second-Quarter 2016 Financial Results
9.2.15 Aug 02, 2016: DexCom Reports Second Quarter 2016 Financial Results
9.2.16 Jul 28, 2016: Thermo Fisher Scientific Reports Second Quarter 2016 Results
9.2.17 Jul 19, 2016: Johnson & Johnson Reports 2016 Second-Quarter Results
9.2.18 Jul 12, 2016: PositiveID Announces Highlights for First Half of 2016
9.2.19 Jun 06, 2016: Sangui BioTech: Third Quarter Report
9.2.20 Jun 02, 2016: Fuel3D announces first enterprise client scanning solution
9.2.21 May 17, 2016: PositiveID Reports Q1 2016 Revenue of $1.7 Million, Up from $0.1M in Q1 2015
9.2.22 May 05, 2016: BD Announces Results For 2016 Second Fiscal Quarter
9.2.23 Apr 27, 2016: DexCom Reports First Quarter 2016 Financial Results
9.2.24 Apr 19, 2016: Johnson & Johnson Reports 2016 First-Quarter Results
9.2.25 Apr 11, 2016: SteadyMed Announces Initiation Of Inter Partes Review Proceedings By U.S. Patent And Trademark Office Against A United Therapeutics Patent
9.2.26 Mar 10, 2016: Immunotherapeutic Potential of Manocept Platform Reviewed in the Journal Nuclear Medicine and Biology
9.2.27 Feb 23, 2016: DexCom Reports Fourth Quarter and Full Year 2015 Financial Results
9.2.28 Feb 03, 2016: BD Announces Results For 2016 First Fiscal Quarter
9.2.29 Jan 26, 2016: Johnson & Johnson Reports 2015 Fourth-Quarter Results
9.3 Legal And Regulatory
9.3.1 Dec 08, 2016: Khang & Khang Announces Securities Class Action Lawsuit against Alere and Reminds Investors with Losses to Contact the Firm
9.3.2 Dec 07, 2016: Abbott Seeks To Terminate Alere Acquisition
9.3.3 Aug 10, 2016: CDC Exercises Contract Option Valued at $11.6 Million to Further Support Emergent BioSolutions’ Vaccinia Immune Globulin
9.3.4 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic
9.3.5 Mar 21, 2016: LifeWatch: Supplemental information on Highmark arbitration case
9.3.6 Mar 17, 2016: LifeWatch announces arbitration decision in Highmark case
9.3.7 Mar 14, 2016: DECN Subsidiaries Sue Johnson & Johnson and Several Divisions for Patent Infringement
9.3.8 Feb 29, 2016: Baron & Budd Investigating Potential Lawsuits Against Johnson & Johnson Regarding Link Between Talcum Powder and Ovarian Cancer
9.4 Other Significant Developments
9.4.1 Dec 14, 2016: One Drop Announces Inaugural Members Of One Drop | Experts Advisory Board
9.4.2 Oct 20, 2016: Actor Derek Theler and Dexcom Take Center Stage to Raise Awareness of Diabetes
9.4.3 Aug 17, 2016: Livongo for Diabetes Program Generates Positive Clinical, Financial Outcomes
9.4.4 Jun 21, 2016: PositiveID’s Mobile Lab Business Completed 80 Projects in the First Half of 2016
9.4.5 May 17, 2016: Protagonist Therapeutics to Present New Data on PTG-200 at Digestive Disease Week 2016
9.4.6 May 10, 2016: Thermo Fisher Scientific Reports Progress on Global Corporate Social Responsibility
9.4.7 May 03, 2016: Sentnyl Therapeutics, Re-Launches Abstral in the United States
9.4.8 Apr 06, 2016: Medtronic Statement on U.S. Department of Treasury's Recent Temporary and Proposed Regulations
9.5 Product News
9.5.1 Sep 12, 2016: Indiana University Research and Technology issued record 53 U.S. patents in 2015-16
9.5.2 Jun 28, 2016: Trividia Health Initiates Voluntary Recall of Certain Lots of TRUEread, TRUEbalance, TRUEtrack & TRUEtest blood glucose test strip
9.5.3 Apr 26, 2016: New Vigilant Diabetes Management Companion Launched in U.S. That Alerts Users to Risk of Severe Hypoglycemia in Next 24 Hours
9.5.4 Mar 09, 2016: Dexcom continuous glucose monitor receivers
9.6 Strategy And Business Planning
9.6.1 Nov 22, 2016: Highly Pathogenic Bird Flu Spreading Across Europe and Asia; BiondVax’s Universal Flu Vaccine Candidate Also Covers these Potential Pandemic Strains
9.6.2 Nov 14, 2016: Diabetes Management Leader Dexcom Expands Presence in EMEA Markets with new Edinburgh HQ
9.6.3 Jun 20, 2016: Dexcom to Expand Manufacturing Operations to Greater Phoenix, Arizona
9.6.4 Jan 25, 2016: AstraZeneca partners with peers and academia to establish translational research fund
9.6.5 Jan 21, 2016: Singularity University and BD Announce Collaboration Dedicated to Address Global Healthcare Challenges
10 Appendix
10.1 Research Methodology
10.1.1 Coverage
10.1.2 Secondary Research
10.1.3 Primary Research
10.1.4 Company Share Analysis
10.1.5 Distribution Share Analysis
10.1.6 Benchmarking
10.2 GlobalData Consulting
10.3 Contact Us
10.4 Disclaimer
1.1 List of Tables
Table 1: Glucose Monitoring Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2008-2022
Table 2: Glucose Monitoring Market, North America, Category Comparison by Revenue ($m), USD Constant, 2008-2022
Table 3: Glucose Monitoring Market, North America, Revenue ($m), Historic, USD Constant, 2008-2015
Table 4: Glucose Monitoring Market, North America, Revenue ($m), Forecast, USD Constant, 2015-2022
Table 5: Glucose Monitoring Market, North America, Volume (Units), 2008-2022
Table 6: Glucose Monitoring Market, North America, Volume (Units), Historic, 2008-2015
Table 7: Glucose Monitoring Market, North America, Volume (Units), Forecast, 2015-2022
Table 8: Glucose Monitoring Market, North America, Company Share by Revenue ($m), USD Constant, 2015
Table 9: Glucose Monitoring Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015
Table 10: Glucose Monitoring Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 11: Blood Glucose Meters Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015
Table 12: Blood Glucose Meters Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 13: Glucose Monitoring Market, Canada, Volume (Units), Historic, 2008-2015
Table 14: Glucose Monitoring Market, Canada, Volume (Units), Forecast, 2015-2022
Table 15: Blood Glucose Meters Market, Canada, Volume (Units), Historic, 2008-2015
Table 16: Blood Glucose Meters Market, Canada, Volume (Units), Forecast, 2015-2022
Table 17: Glucose Monitoring Market, Canada, Average Price ($) Historic, 2008-2022
Table 18: Glucose Monitoring Market, Canada, Average Price ($), Forecast, 2015-2022
Table 19: Glucose Monitoring Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2014-2015
Table 20: Glucose Monitoring Market, Canada, Company Share by Revenue ($m), USD Constant, 2015
Table 21: Glucose Monitoring Market, Mexico, Revenue ($m), USD Constant, Historic, 2008-2015
Table 22: Glucose Monitoring Market, Mexico, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 23: Blood Glucose Meters Market, Mexico, Revenue ($m), USD Constant, Historic, 2008-2015
Table 24: Blood Glucose Meters Market, Mexico, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 25: Glucose Monitoring Market, Mexico, Volume (Units), Historic, 2008-2015
Table 26: Glucose Monitoring Market, Mexico, Volume (Units), Forecast, 2015-2022
Table 27: Blood Glucose Meters Market, Mexico, Volume (Units), Historic, 2008-2015
Table 28: Blood Glucose Meters Market, Mexico, Volume (Units), Forecast, 2015-2022
Table 29: Glucose Monitoring Market, Mexico, Average Price ($) Historic, 2008-2022
Table 30: Glucose Monitoring Market, Mexico, Average Price ($), Forecast, 2015-2022
Table 31: Glucose Monitoring Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2014-2015
Table 32: Glucose Monitoring Market, Mexico, Company Share by Revenue ($m), USD Constant, 2015
Table 33: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Table 34: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 35: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Table 36: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 37: Glucose Monitoring Market, United States, Volume (Units), Historic, 2008-2015
Table 38: Glucose Monitoring Market, United States, Volume (Units), Forecast, 2015-2022
Table 39: Blood Glucose Meters Market, United States, Volume (Units), Historic, 2008-2015
Table 40: Blood Glucose Meters Market, United States, Volume (Units), Forecast, 2015-2022
Table 41: Glucose Monitoring Market, United States, Average Price ($), Historic, 2008-2015
Table 42: Glucose Monitoring Market, United States, Average Price ($), Forecast, 2015-2022
Table 43: Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), USD Constant, 2014-2015
Table 44: Glucose Monitoring Market, United States, Company Share by Revenue ($m), USD Constant, 2015
Table 45: Glucose Monitoring Market Pipeline Products
1.2 List of Figures
Figure 1: Glucose Monitoring Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2008-2022
Figure 2: Glucose Monitoring Market, North America, Category Comparison by Revenue ($m), USD Constant, 2008-2022
Figure 3: Glucose Monitoring Market, North America, Revenue ($m), Historic, USD Constant, 2008-2015
Figure 4: Glucose Monitoring Market, North America, Revenue ($m), Forecast, USD Constant, 2015-2022
Figure 5: Glucose Monitoring Market, North America, Volume (Units), 2008-2022
Figure 6: Glucose Monitoring Market, North America, Volume (Units), Historic, 2008-2015
Figure 7: Glucose Monitoring Market, North America, Volume (Units), Forecast, 2015-2022
Figure 8: Glucose Monitoring Market, North America, Company Share (%) 2015
Figure 9: Glucose Monitoring Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 10: Glucose Monitoring Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 11: Blood Glucose Meters Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 12: Blood Glucose Meters Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 13: Glucose Monitoring Market, Canada, Volume (Units), Historic, 2008-2015
Figure 14: Glucose Monitoring Market, Canada, Volume (Units), Forecast, 2015-2022
Figure 15: Blood Glucose Meters Market, Canada, Volume (Units), Historic, 2008-2015
Figure 16: Blood Glucose Meters Market, Canada, Volume (Units), Forecast, 2015-2022
Figure 17: Glucose Monitoring Market, Canada, Company Share (%) 2015
Figure 18: Glucose Monitoring Market, Mexico, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 19: Glucose Monitoring Market, Mexico, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 20: Blood Glucose Meters Market, Mexico, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 21: Blood Glucose Meters Market, Mexico, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 22: Glucose Monitoring Market, Mexico, Volume (Units), Historic, 2008-2015
Figure 23: Glucose Monitoring Market, Mexico, Volume (Units), Forecast, 2015-2022
Figure 24: Blood Glucose Meters Market, Mexico, Volume (Units), Historic, 2008-2015
Figure 25: Blood Glucose Meters Market, Mexico, Volume (Units), Forecast, 2015-2022
Figure 26: Glucose Monitoring Market, Mexico, Company Share (%) 2015
Figure 27: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 28: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 29: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 30: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 31: Glucose Monitoring Market, United States, Volume (Units), Historic, 2008-2015
Figure 32: Glucose Monitoring Market, United States, Volume (Units), Forecast, 2015-2022
Figure 33: Blood Glucose Meters Market, United States, Volume (Units), Historic, 2008-2015
Figure 34: Blood Glucose Meters Market, United States, Volume (Units), Forecast, 2015-2022
Figure 35: Glucose Monitoring Market, United States, Company Share (%) 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report